• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞在帕金森病和亨廷顿病再生医学中的应用。

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.

机构信息

LUNAM Université, France.

出版信息

Curr Med Chem. 2012;19(35):6018-35.

PMID:22963567
Abstract

Cell transplantation has been proposed as a means of replacing specific cell populations lost through neurodegenerative processes such as that seen in Parkinson's or Huntington's diseases. Improvement of the clinical symptoms has been observed in a number of Parkinson and Huntington's patients transplanted with freshly isolated fetal brain tissue but such restorative approach is greatly hampered by logistic and ethical concerns relative to the use of fetal tissue, in addition to potential side effects that remain to be controlled. In this context, stem cells that are capable of self-renewal and can differentiate into neurons, have received a great deal of interest, as demonstrated by the numerous studies based on the transplantation of neural stem/progenitor cells, embryonic stem cells or mesenchymal stem cells into animal models of Parkinson's or Huntington's diseases. More recently, the induction of pluripotent stem cells from somatic adult cells has raised a new hope for the treatment of neurodegenerative diseases. In the present article, we review the main experimental approaches to assess the efficiency of cell-based therapy for Parkinson's or Huntington's diseases, and discuss the recent advances in using stem cells to replace lost dopaminergic mesencephalic or striatal neurons. Characteristics of the different stem cells are extensively examined with a special attention to their ability of producing neurotrophic or immunosuppressive factors, as these may provide a favourable environment for brain tissue repair and long-term survival of transplanted cells in the central nervous system. Thus, stem cell therapy can be a valuable tool in regenerative medicine.

摘要

细胞移植被提议作为一种替代特定细胞群体的手段,这些细胞群体通过神经退行性过程丧失,如帕金森病或亨廷顿病中所见。许多帕金森病和亨廷顿病患者接受了新鲜分离的胎儿脑组织移植,观察到了临床症状的改善,但这种恢复方法受到与使用胎儿组织相关的后勤和伦理问题的严重阻碍,此外,潜在的副作用也需要得到控制。在这种情况下,能够自我更新并能分化为神经元的干细胞受到了极大的关注,这一点已被基于将神经干细胞/祖细胞、胚胎干细胞或间充质干细胞移植到帕金森病或亨廷顿病动物模型中的众多研究证明。最近,从成体体细胞诱导多能干细胞为治疗神经退行性疾病带来了新的希望。在本文中,我们回顾了评估基于细胞的帕金森病或亨廷顿病治疗效率的主要实验方法,并讨论了使用干细胞替代丧失的多巴胺能中脑或纹状体神经元的最新进展。不同干细胞的特征被广泛检查,特别关注它们产生神经营养或免疫抑制因子的能力,因为这些因子可能为脑组织修复和移植细胞在中枢神经系统中的长期存活提供有利环境。因此,干细胞治疗可以成为再生医学的有价值工具。

相似文献

1
The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.干细胞在帕金森病和亨廷顿病再生医学中的应用。
Curr Med Chem. 2012;19(35):6018-35.
2
Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.帕金森病多巴胺能细胞替代和再生策略的研究进展。
ACS Chem Neurosci. 2019 Feb 20;10(2):839-851. doi: 10.1021/acschemneuro.8b00389. Epub 2018 Oct 24.
3
Neural stem cell-based treatment for neurodegenerative diseases.基于神经干细胞的神经退行性疾病治疗方法。
Neuropathology. 2013 Oct;33(5):491-504. doi: 10.1111/neup.12020. Epub 2013 Feb 5.
4
Stem cell transplantation for Huntington's diseases.干细胞移植治疗亨廷顿病。
Methods. 2018 Jan 15;133:104-112. doi: 10.1016/j.ymeth.2017.08.017. Epub 2017 Sep 1.
5
Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.间充质干细胞作为多巴胺能神经元的来源:一种潜在的帕金森病细胞疗法
Curr Stem Cell Res Ther. 2017;12(4):326-347. doi: 10.2174/1574888X12666161114122059.
6
Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?人类胎儿来源的干细胞在亨廷顿舞蹈症的细胞替代疗法中是否有一席之地?
Neurochem Int. 2017 Jun;106:114-121. doi: 10.1016/j.neuint.2017.01.016. Epub 2017 Jan 27.
7
[Stem cell therapy for neurodegenerative disorders].[用于神经退行性疾病的干细胞疗法]
Ugeskr Laeger. 2010 Sep 20;172(38):2604-7.
8
In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.用于神经疾病动物模型的三维基质附着胚胎干细胞衍生神经聚集体的体外生成。
Curr Protoc Stem Cell Biol. 2012 May;Chapter 2:Unit 2D.11. doi: 10.1002/9780470151808.sc02d11s21.
9
Induced neural stem cells as a means of treatment in Huntington's disease.诱导神经干细胞作为治疗亨廷顿舞蹈症的一种手段。
Expert Opin Biol Ther. 2017 Nov;17(11):1333-1343. doi: 10.1080/14712598.2017.1365133. Epub 2017 Aug 9.
10
Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.帕金森病发病机制对神经退行性疾病中细胞替代策略和药物发现的影响。
CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):907-20. doi: 10.2174/1871527311201070907.

引用本文的文献

1
MSC-Derived Exosomes can Enhance the Angiogenesis of Human Brain MECs and Show Therapeutic Potential in a Mouse Model of Parkinson's Disease.间充质干细胞衍生的外泌体可增强人脑海微血管内皮细胞的血管生成,并在帕金森病小鼠模型中显示出治疗潜力。
Aging Dis. 2021 Aug 1;12(5):1211-1222. doi: 10.14336/AD.2020.1221. eCollection 2021 Aug.
2
Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?免疫反应是神经退行性疾病细胞治疗的瓶颈吗?
Front Cell Neurosci. 2020 Aug 11;14:250. doi: 10.3389/fncel.2020.00250. eCollection 2020.
3
Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy.
神经干细胞来源的小细胞外囊泡通过激活自噬减轻创伤性脊髓损伤后的细胞凋亡和神经炎症。
Cell Death Dis. 2019 Apr 18;10(5):340. doi: 10.1038/s41419-019-1571-8.
4
Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.羊水细胞条件培养液可保护亨廷顿病 R6/2 小鼠模型纹状体的退行性变,并改善其运动缺陷。
J Cell Mol Med. 2019 Feb;23(2):1581-1592. doi: 10.1111/jcmm.14113. Epub 2018 Dec 25.
5
Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives.基于磁共振成像的细胞疗法监测进展:未来展望。
Int J Mol Sci. 2017 Jan 19;18(1):198. doi: 10.3390/ijms18010198.
6
Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.干细胞治疗在神经退行性和代谢性疾病中的当前视角。
Mol Neurobiol. 2017 Nov;54(9):7276-7296. doi: 10.1007/s12035-016-0217-4. Epub 2016 Nov 4.
7
Expression Pattern of Neuronal Markers in PB-MSCs Treated by Growth Factors Noggin, bFGF and EGF.生长因子Noggin、碱性成纤维细胞生长因子(bFGF)和表皮生长因子(EGF)处理的外周血间充质干细胞中神经元标志物的表达模式
Int J Mol Cell Med. 2015 Fall;4(4):209-17.
8
Different Tissue-Derived Stem Cells: A Comparison of Neural Differentiation Capability.不同组织来源的干细胞:神经分化能力的比较
PLoS One. 2015 Oct 30;10(10):e0140790. doi: 10.1371/journal.pone.0140790. eCollection 2015.
9
Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.在帕金森病体外模型中,与释放神经营养因子-3的药理活性微载体复合的人干细胞的存活、分化及神经保护机制
Stem Cells Transl Med. 2015 Jun;4(6):670-84. doi: 10.5966/sctm.2014-0139. Epub 2015 Apr 29.
10
A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy.随后将人类神经祖细胞移植到退化的视网膜中不会损害初始移植物的存活或治疗效果。
Transl Vis Sci Technol. 2015 Feb 10;4(1):7. doi: 10.1167/tvst.4.1.7. eCollection 2015 Feb.